Privia Health Group, Inc. Operating Lease Cost
Privia Health Group, Inc. (PRVA) reported Operating Lease Cost of $3.16 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-02-27
- Privia Health Group, Inc. operating lease, cost for the quarter ending 2022-12-31 was $656.00K, a 7.61% decline year-over-year.
- Privia Health Group, Inc. operating lease, cost for the quarter ending 2022-09-30 was $683.00K, a 43.79% increase year-over-year.
- Privia Health Group, Inc. operating lease, cost for the quarter ending 2022-06-30 was $666.00K, a 37.32% increase year-over-year.
- Privia Health Group, Inc. operating lease, cost for the quarter ending 2022-03-31 was $664.00K, a 48.88% increase year-over-year.
- Privia Health Group, Inc. operating lease, cost for fiscal 2025 was $3.16M, a 13.89% increase from fiscal 2024.
- Privia Health Group, Inc. operating lease, cost for fiscal 2024 was $2.77M, a 2.82% increase from fiscal 2023.
- Privia Health Group, Inc. operating lease, cost for fiscal 2023 was $2.70M, a 1.01% increase from fiscal 2022.
- Privia Health Group, Inc. operating lease, cost for fiscal 2022 was $2.67M, a 26.13% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.16M 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $2.77M 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $2.70M 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $656.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.34M derived: sum of 2 quarters · filed 2024-02-27 | $2.00M derived: sum of 3 quarters · filed 2024-02-27 | $2.67M 10-K · filed 2024-02-27 |
| 2022-09-30 | $683.00K 10-Q · filed 2022-11-10 | $1.35M derived: sum of 2 quarters · filed 2022-11-10 | $2.01M 10-Q · filed 2022-11-10 | $2.72M derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-06-30 | $666.00K 10-Q · filed 2022-08-11 | $1.33M 10-Q · filed 2022-08-11 | $2.04M derived: sum of 3 quarters · filed 2023-03-01 | $2.52M derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-03-31 | $664.00K 10-Q · filed 2022-05-12 | $1.37M derived: sum of 2 quarters · filed 2023-03-01 | $1.85M derived: sum of 3 quarters · filed 2023-03-01 | $2.33M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-12-31 | $710.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.19M derived: sum of 2 quarters · filed 2023-03-01 | $1.67M derived: sum of 3 quarters · filed 2023-03-01 | $2.12M 10-K · filed 2023-03-01 |
| 2021-09-30 | $475.00K 10-Q · filed 2022-11-10 | $960.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.41M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $485.00K 10-Q · filed 2022-08-11 | $931.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $446.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |